FDA lifts hold on Ocugen’s COVID-19 vaccine trial. But is it too late for the shot?news2022-05-23T13:16:40+00:00May 23rd, 2022|Fierce Pharma|
Merck KGaA lines up 370 new jobs with $470M manufacturing boost in Irelandnews2022-05-23T12:29:59+00:00May 23rd, 2022|Fierce Pharma|
Vir, WuXi Biologics terminate COVID antibody pact as US rollout faces uncertain futurenews2022-05-23T11:26:47+00:00May 23rd, 2022|Fierce Pharma|
Sanofi’s Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitisnews2022-05-20T19:45:57+00:00May 20th, 2022|Fierce Pharma|
Sanofi’s Xenpozyme, Lilly’s Olumiant among batch of new EU approvalsnews2022-05-20T14:54:53+00:00May 20th, 2022|Fierce Pharma|
Gilead Sciences nabs top HIV philanthropic fundraising spot in the US, passing Gates Foundationnews2022-05-20T14:06:31+00:00May 20th, 2022|Fierce Pharma|
Novartis hands over Tasigna patent as part of coalition with Roche, BMS and more to boost cancer drug access in poor countriesnews2022-05-20T13:40:37+00:00May 20th, 2022|Fierce Pharma|
FDA lays out framework for manufacturers and developers to tackle drug shortagesnews2022-05-20T13:13:30+00:00May 20th, 2022|Fierce Pharma|
Moderna CEO Stéphane Bancel, for helping slay COVID, knighted in Francenews2022-05-20T12:02:26+00:00May 20th, 2022|Fierce Pharma|
AbbVie faces yet another ‘white-coat’ lawsuit claiming it used kickbacks to help promote Humiranews2022-05-20T11:17:02+00:00May 20th, 2022|Fierce Pharma|
